-
1
-
-
20344396863
-
Prevention of atrial fibrillation with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: A meta-analysis
-
Healey JS, Baranchuk A, Crystal E, Morillo CA, Garfinkle M, Yusuf S. Prevention of atrial fibrillation with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: A meta-analysis. J Am Coll Cardiol 2005; 45: 1832-1839.
-
(2005)
J Am Coll Cardiol
, vol.45
, pp. 1832-1839
-
-
Healey, J.S.1
Baranchuk, A.2
Crystal, E.3
Morillo, C.A.4
Garfinkle, M.5
Yusuf, S.6
-
2
-
-
0036218201
-
Therapeutic implications of atrial fibrillation mechanisms: Can mechanistic insights be used to improve AF management?
-
Nattel S. Therapeutic implications of atrial fibrillation mechanisms: can mechanistic insights be used to improve AF management? Cardiovasc Res 2002; 54: 347-360.
-
(2002)
Cardiovasc Res
, vol.54
, pp. 347-360
-
-
Nattel, S.1
-
3
-
-
37449009956
-
Structural and functional remodeling of the left atrium: Clinical and therapeutic implications for atrial fibrillation
-
Casaclang-Verzosa G, Gersh BJ, Tsang TS. Structural and functional remodeling of the left atrium: Clinical and therapeutic implications for atrial fibrillation. J Am Coll Cardiol 2008; 51: 1-11.
-
(2008)
J Am Coll Cardiol
, vol.51
, pp. 1-11
-
-
Casaclang-Verzosa, G.1
Gersh, B.J.2
Tsang, T.S.3
-
4
-
-
34347208265
-
Upstream therapy for atrial fibrillation
-
Kumagai K. Upstream therapy for atrial fibrillation. Circ J 2007: (Suppl A): A75-A81.
-
(2007)
Circ J
, Issue.SUPPL. A
-
-
Kumagai, K.1
-
5
-
-
1842471341
-
Nonchannel drug targets in atrial fibrillation
-
Goette A, Lendeckel U. Nonchannel drug targets in atrial fibrillation. Pharmacol Ther 2004; 102: 17-36.
-
(2004)
Pharmacol Ther
, vol.102
, pp. 17-36
-
-
Goette, A.1
Lendeckel, U.2
-
6
-
-
0036107461
-
The new oral angiotensin II antagonist olmesartan medoxomil: A concise overview
-
Brunner HR. The new oral angiotensin II antagonist olmesartan medoxomil: a concise overview. J Hum Hypertens 2002; 16(Suppl 2): S13-S16.
-
(2002)
J Hum Hypertens
, vol.16
, Issue.SUPPL. 2
-
-
Brunner, H.R.1
-
7
-
-
37149055770
-
Reverse-remodeling effects of angiotensin II type 1 receptor blocker in a canine atrial fibrillation model
-
Nakashima H, Kumagai K. Reverse-remodeling effects of angiotensin II type 1 receptor blocker in a canine atrial fibrillation model. Circ J 2007; 71: 1977-1982.
-
(2007)
Circ J
, vol.71
, pp. 1977-1982
-
-
Nakashima, H.1
Kumagai, K.2
-
8
-
-
35348948565
-
Angiotensin II type 1 receptor inhibition is associated with reduced tachyarrhythmia-induced ventricular interstitial fibrosis in a goat atrial fibrillation model
-
Chrysostomakis SI, Karalis IK, Simantirakis EN, Koutsopoulos AV, Mavrakis HE, Chlouverakis GI, Vardas PE. Angiotensin II type 1 receptor inhibition is associated with reduced tachyarrhythmia-induced ventricular interstitial fibrosis in a goat atrial fibrillation model. Cardiovasc Drugs Ther 2007; 21: 357-365.
-
(2007)
Cardiovasc Drugs Ther
, vol.21
, pp. 357-365
-
-
Chrysostomakis, S.I.1
Karalis, I.K.2
Simantirakis, E.N.3
Koutsopoulos, A.V.4
Mavrakis, H.E.5
Chlouverakis, G.I.6
Vardas, P.E.7
-
9
-
-
39349099135
-
Atrial fibrosis: Mechanisms and clinical relevance in atrial fibrillation
-
Burstein B, Nattel S. Atrial fibrosis: Mechanisms and clinical relevance in atrial fibrillation. J Am Coll Cardiol 2008; 51: 802-809.
-
(2008)
J Am Coll Cardiol
, vol.51
, pp. 802-809
-
-
Burstein, B.1
Nattel, S.2
-
10
-
-
0034083871
-
Chronic AT, blockade stimulates extracellular collagen type 1 degradation and reverses myocardial fibrosis in spontaneously hypertensive rats
-
Varo N, Iraburu MJ, Varela M, López B, Etayo JC, Díez J. Chronic AT, blockade stimulates extracellular collagen type 1 degradation and reverses myocardial fibrosis in spontaneously hypertensive rats. Hypertension 2000; 35: 1197-1202.
-
(2000)
Hypertension
, vol.35
, pp. 1197-1202
-
-
Varo, N.1
Iraburu, M.J.2
Varela, M.3
López, B.4
Etayo, J.C.5
Díez, J.6
-
11
-
-
0026794602
-
The role of renin-angiotensin system in the control of cell commuflication in the heart: Effects of enalapril and angiotensin II
-
De Mello W, Altieri P. The role of renin-angiotensin system in the control of cell commuflication in the heart: Effects of enalapril and angiotensin II. J Cardiovasc Pharmacol 1992; 20: 643-651.
-
(1992)
J Cardiovasc Pharmacol
, vol.20
, pp. 643-651
-
-
De Mello, W.1
Altieri, P.2
-
12
-
-
11144219792
-
Absence of acute effects of angiotensin II on atrial electro-physiology in humans
-
Kistler PM, Davidson NC, Sanders P, Fynn SP, Stevenson IH, Spence SJ, Vohra JK, Sparks PB, Kalman JM. Absence of acute effects of angiotensin II on atrial electro-physiology in humans. J Am Coll Cardial 2005; 45: 154-156.
-
(2005)
J Am Coll Cardial
, vol.45
, pp. 154-156
-
-
Kistler, P.M.1
Davidson, N.C.2
Sanders, P.3
Fynn, S.P.4
Stevenson, I.H.5
Spence, S.J.6
Vohra, J.K.7
Sparks, P.B.8
Kalman, J.M.9
-
13
-
-
37549037885
-
Is there a role for remodeled connexins in AF? No simple answers
-
Duffy HS, Wit AL. Is there a role for remodeled connexins in AF? No simple answers. J Mol Cell Cardiol 2008; 44: 4-13.
-
(2008)
J Mol Cell Cardiol
, vol.44
, pp. 4-13
-
-
Duffy, H.S.1
Wit, A.L.2
-
14
-
-
0034717680
-
Phosphorylation of connexin 43 on serine368 by protein kinase C regulates gap junctional communication
-
Lampe PD, TenBroek EM, Burt JM, Johnson RG, Lau AF. Phosphorylation of connexin 43 on serine368 by protein kinase C regulates gap junctional communication. J Mol Cell Cardiol 2000; 149: 1503-1512.
-
(2000)
J Mol Cell Cardiol
, vol.149
, pp. 1503-1512
-
-
Lampe, P.D.1
TenBroek, E.M.2
Burt, J.M.3
Johnson, R.G.4
Lau, A.F.5
-
15
-
-
0037076797
-
Frequency-dependent breakdown of wave propagation into fibrillatory conduction across the pectinate muscle network in the isolated sheep right atrium
-
Berenfeld O, Zaitsev AV, Mironov SF, Pertsov AM, Jalife J. Frequency-dependent breakdown of wave propagation into fibrillatory conduction across the pectinate muscle network in the isolated sheep right atrium. Circ Res 2002; 90: 1173-1180.
-
(2002)
Circ Res
, vol.90
, pp. 1173-1180
-
-
Berenfeld, O.1
Zaitsev, A.V.2
Mironov, S.F.3
Pertsov, A.M.4
Jalife, J.5
-
16
-
-
33847250494
-
Nonantiarrhythmic drug therapy for atrial fibrillation
-
Murray KT, Mace LC, Yang Z. Nonantiarrhythmic drug therapy for atrial fibrillation. Heart Rhythm 2007; 4(3 Suppl): S88-S90.
-
(2007)
Heart Rhythm
, vol.4
, Issue.3 SUPPL.
-
-
Murray, K.T.1
Mace, L.C.2
Yang, Z.3
-
17
-
-
0028896199
-
Cardiac refractoriness in rats is reduced by angiotensin II
-
De Mello WC, Crespo MJ. Cardiac refractoriness in rats is reduced by angiotensin II. J Cardiovasc Pharmacol 1995; 25: 5156.
-
(1995)
J Cardiovasc Pharmacol
, vol.25
, pp. 5156
-
-
De Mello, W.C.1
Crespo, M.J.2
|